aluates Reports

$ 0.0

Automative

Global Targeted Alpha-particle Therapy Market Research Report 2024

Published Date: May 2024

Report Code: QYRE-Auto-21X17111

BUY CHAPTERS

Global Targeted Alpha-particle Therapy Market Research Report 2024

Code: QYRE-Auto-21X17111

Report

May 2024

Pages:72

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Bayer

Orano Med

Perspective Therapeutics

Oncoinvent AS

Ablaze Pharma

ARTBIO

Fusion Pharmaceuticals(AstraZeneca)

AlphaGen Therapeutics

Targeted Alpha-particle Therapy Market

Targeted alpha-particle therapy (or TAT) is an in-development method of targeted radionuclide therapy of various cancers. It employs radioactive substances which undergo alpha decay to treat diseased tissue at close proximity. It has the potential to provide highly targeted treatment, especially to microscopic tumour cells. Targets include leukemias, lymphomas, gliomas, melanoma, and peritoneal carcinomatosis. As in diagnostic nuclear medicine, appropriate radionuclides can be chemically bound to a targeting biomolecule which carries the combined radiopharmaceutical to a specific treatment point.

The global Targeted Alpha-particle Therapy market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of %during the forecast period 2024-2030.

North American market for Targeted Alpha-particle Therapy is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

Asia-Pacific market for Targeted Alpha-particle Therapy is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

The global market for Targeted Alpha-particle Therapy in Immunotherapy is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

The major global companies of Targeted Alpha-particle Therapy include Bayer, Orano Med, Oncoinvent AS, Perspective Therapeutics, Ablaze Pharma, ARTBIO, Fusion Pharmaceuticals(AstraZeneca), AlphaGen Therapeutics, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.

This report aims to provide a comprehensive presentation of the global market for Targeted Alpha-particle Therapy, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Targeted Alpha-particle Therapy.

The Targeted Alpha-particle Therapy market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Targeted Alpha-particle Therapy market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Targeted Alpha-particle Therapy companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Targeted Alpha-particle Therapy Market Report

Report Metric	Details
Report Name	Targeted Alpha-particle Therapy Market
Segment by Type	Actinium-225 Astatine-211 Lead-212 Bismuth-213 Others
Segment by Application	Immunotherapy Peritoneal Carcinomas Bone Metastases Leukaemia Melanomas Solid Tumours
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Bayer, Orano Med, Oncoinvent AS, Perspective Therapeutics, Ablaze Pharma, ARTBIO, Fusion Pharmaceuticals(AstraZeneca), AlphaGen Therapeutics
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Targeted Alpha-particle Therapy company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Targeted Alpha-particle Therapy Market report?

Ans: The main players in the Targeted Alpha-particle Therapy Market are Bayer, Orano Med, Oncoinvent AS, Perspective Therapeutics, Ablaze Pharma, ARTBIO, Fusion Pharmaceuticals(AstraZeneca), AlphaGen Therapeutics

What are the Application segmentation covered in the Targeted Alpha-particle Therapy Market report?

Ans: The Applications covered in the Targeted Alpha-particle Therapy Market report are Immunotherapy, Peritoneal Carcinomas, Bone Metastases, Leukaemia, Melanomas, Solid Tumours

What are the Type segmentation covered in the Targeted Alpha-particle Therapy Market report?

Ans: The Types covered in the Targeted Alpha-particle Therapy Market report are Actinium-225, Astatine-211, Lead-212, Bismuth-213, Others

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Targeted Alpha-particle Therapy Market Size Growth Rate by Type: 2019 VS 2023 VS 2030

1.2.2 Actinium-225

1.2.3 Astatine-211

1.2.4 Lead-212

1.2.5 Bismuth-213

1.2.6 Others

1.3 Market by Application

1.3.1 Global Targeted Alpha-particle Therapy Market Growth by Application: 2019 VS 2023 VS 2030

1.3.2 Immunotherapy

1.3.3 Peritoneal Carcinomas

1.3.4 Bone Metastases

1.3.5 Leukaemia

1.3.6 Melanomas

1.3.7 Solid Tumours

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Targeted Alpha-particle Therapy Market Perspective (2019-2030)

2.2 Global Targeted Alpha-particle Therapy Growth Trends by Region

2.2.1 Global Targeted Alpha-particle Therapy Market Size by Region: 2019 VS 2023 VS 2030

2.2.2 Targeted Alpha-particle Therapy Historic Market Size by Region (2019-2024)

2.2.3 Targeted Alpha-particle Therapy Forecasted Market Size by Region (2025-2030)

2.3 Targeted Alpha-particle Therapy Market Dynamics

2.3.1 Targeted Alpha-particle Therapy Industry Trends

2.3.2 Targeted Alpha-particle Therapy Market Drivers

2.3.3 Targeted Alpha-particle Therapy Market Challenges

2.3.4 Targeted Alpha-particle Therapy Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Targeted Alpha-particle Therapy Players by Revenue

3.1.1 Global Top Targeted Alpha-particle Therapy Players by Revenue (2019-2024)

3.1.2 Global Targeted Alpha-particle Therapy Revenue Market Share by Players (2019-2024)

3.2 Global Targeted Alpha-particle Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by Targeted Alpha-particle Therapy Revenue

3.4 Global Targeted Alpha-particle Therapy Market Concentration Ratio

3.4.1 Global Targeted Alpha-particle Therapy Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Targeted Alpha-particle Therapy Revenue in 2023

3.5 Global Key Players of Targeted Alpha-particle Therapy Head office and Area Served

3.6 Global Key Players of Targeted Alpha-particle Therapy, Product and Application

3.7 Global Key Players of Targeted Alpha-particle Therapy, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Targeted Alpha-particle Therapy Breakdown Data by Type

4.1 Global Targeted Alpha-particle Therapy Historic Market Size by Type (2019-2024)

4.2 Global Targeted Alpha-particle Therapy Forecasted Market Size by Type (2025-2030)

5 Targeted Alpha-particle Therapy Breakdown Data by Application

5.1 Global Targeted Alpha-particle Therapy Historic Market Size by Application (2019-2024)

5.2 Global Targeted Alpha-particle Therapy Forecasted Market Size by Application (2025-2030)

6 North America

6.1 North America Targeted Alpha-particle Therapy Market Size (2019-2030)

6.2 North America Targeted Alpha-particle Therapy Market Growth Rate by Country: 2019 VS 2023 VS 2030

6.3 North America Targeted Alpha-particle Therapy Market Size by Country (2019-2024)

6.4 North America Targeted Alpha-particle Therapy Market Size by Country (2025-2030)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Targeted Alpha-particle Therapy Market Size (2019-2030)

7.2 Europe Targeted Alpha-particle Therapy Market Growth Rate by Country: 2019 VS 2023 VS 2030

7.3 Europe Targeted Alpha-particle Therapy Market Size by Country (2019-2024)

7.4 Europe Targeted Alpha-particle Therapy Market Size by Country (2025-2030)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Targeted Alpha-particle Therapy Market Size (2019-2030)

8.2 Asia-Pacific Targeted Alpha-particle Therapy Market Growth Rate by Country: 2019 VS 2023 VS 2030

8.3 Asia-Pacific Targeted Alpha-particle Therapy Market Size by Region (2019-2024)

8.4 Asia-Pacific Targeted Alpha-particle Therapy Market Size by Region (2025-2030)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Targeted Alpha-particle Therapy Market Size (2019-2030)

9.2 Latin America Targeted Alpha-particle Therapy Market Growth Rate by Country: 2019 VS 2023 VS 2030

9.3 Latin America Targeted Alpha-particle Therapy Market Size by Country (2019-2024)

9.4 Latin America Targeted Alpha-particle Therapy Market Size by Country (2025-2030)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Targeted Alpha-particle Therapy Market Size (2019-2030)

10.2 Middle East & Africa Targeted Alpha-particle Therapy Market Growth Rate by Country: 2019 VS 2023 VS 2030

10.3 Middle East & Africa Targeted Alpha-particle Therapy Market Size by Country (2019-2024)

10.4 Middle East & Africa Targeted Alpha-particle Therapy Market Size by Country (2025-2030)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Bayer

11.1.1 Bayer Company Details

11.1.2 Bayer Business Overview

11.1.3 Bayer Targeted Alpha-particle Therapy Introduction

11.1.4 Bayer Revenue in Targeted Alpha-particle Therapy Business (2019-2024)

11.1.5 Bayer Recent Development

11.2 Orano Med

11.2.1 Orano Med Company Details

11.2.2 Orano Med Business Overview

11.2.3 Orano Med Targeted Alpha-particle Therapy Introduction

11.2.4 Orano Med Revenue in Targeted Alpha-particle Therapy Business (2019-2024)

11.2.5 Orano Med Recent Development

11.3 Oncoinvent AS

11.3.1 Oncoinvent AS Company Details

11.3.2 Oncoinvent AS Business Overview

11.3.3 Oncoinvent AS Targeted Alpha-particle Therapy Introduction

11.3.4 Oncoinvent AS Revenue in Targeted Alpha-particle Therapy Business (2019-2024)

11.3.5 Oncoinvent AS Recent Development

11.4 Perspective Therapeutics

11.4.1 Perspective Therapeutics Company Details

11.4.2 Perspective Therapeutics Business Overview

11.4.3 Perspective Therapeutics Targeted Alpha-particle Therapy Introduction

11.4.4 Perspective Therapeutics Revenue in Targeted Alpha-particle Therapy Business (2019-2024)

11.4.5 Perspective Therapeutics Recent Development

11.5 Ablaze Pharma

11.5.1 Ablaze Pharma Company Details

11.5.2 Ablaze Pharma Business Overview

11.5.3 Ablaze Pharma Targeted Alpha-particle Therapy Introduction

11.5.4 Ablaze Pharma Revenue in Targeted Alpha-particle Therapy Business (2019-2024)

11.5.5 Ablaze Pharma Recent Development

11.6 ARTBIO

11.6.1 ARTBIO Company Details

11.6.2 ARTBIO Business Overview

11.6.3 ARTBIO Targeted Alpha-particle Therapy Introduction

11.6.4 ARTBIO Revenue in Targeted Alpha-particle Therapy Business (2019-2024)

11.6.5 ARTBIO Recent Development

11.7 Fusion Pharmaceuticals(AstraZeneca)

11.7.1 Fusion Pharmaceuticals(AstraZeneca) Company Details

11.7.2 Fusion Pharmaceuticals(AstraZeneca) Business Overview

11.7.3 Fusion Pharmaceuticals(AstraZeneca) Targeted Alpha-particle Therapy Introduction

11.7.4 Fusion Pharmaceuticals(AstraZeneca) Revenue in Targeted Alpha-particle Therapy Business (2019-2024)

11.7.5 Fusion Pharmaceuticals(AstraZeneca) Recent Development

11.8 AlphaGen Therapeutics

11.8.1 AlphaGen Therapeutics Company Details

11.8.2 AlphaGen Therapeutics Business Overview

11.8.3 AlphaGen Therapeutics Targeted Alpha-particle Therapy Introduction

11.8.4 AlphaGen Therapeutics Revenue in Targeted Alpha-particle Therapy Business (2019-2024)

11.8.5 AlphaGen Therapeutics Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

Bayer

Orano Med

Perspective Therapeutics

Oncoinvent AS

Ablaze Pharma

ARTBIO

Fusion Pharmaceuticals(AstraZeneca)

AlphaGen Therapeutics

List of Tables

Table 1. Global Targeted Alpha-particle Therapy Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030

Table 2. Key Players of Actinium-225

Table 3. Key Players of Astatine-211

Table 4. Key Players of Lead-212

Table 5. Key Players of Bismuth-213

Table 6. Key Players of Others

Table 7. Global Targeted Alpha-particle Therapy Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030

Table 8. Global Targeted Alpha-particle Therapy Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Table 9. Global Targeted Alpha-particle Therapy Market Size by Region (2019-2024) & (US$ Million)

Table 10. Global Targeted Alpha-particle Therapy Market Share by Region (2019-2024)

Table 11. Global Targeted Alpha-particle Therapy Forecasted Market Size by Region (2025-2030) & (US$ Million)

Table 12. Global Targeted Alpha-particle Therapy Market Share by Region (2025-2030)

Table 13. Targeted Alpha-particle Therapy Market Trends

Table 14. Targeted Alpha-particle Therapy Market Drivers

Table 15. Targeted Alpha-particle Therapy Market Challenges

Table 16. Targeted Alpha-particle Therapy Market Restraints

Table 17. Global Targeted Alpha-particle Therapy Revenue by Players (2019-2024) & (US$ Million)

Table 18. Global Targeted Alpha-particle Therapy Market Share by Players (2019-2024)

Table 19. Global Top Targeted Alpha-particle Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Targeted Alpha-particle Therapy as of 2023)

Table 20. Ranking of Global Top Targeted Alpha-particle Therapy Companies by Revenue (US$ Million) in 2023

Table 21. Global 5 Largest Players Market Share by Targeted Alpha-particle Therapy Revenue (CR5 and HHI) & (2019-2024)

Table 22. Global Key Players of Targeted Alpha-particle Therapy, Headquarters and Area Served

Table 23. Global Key Players of Targeted Alpha-particle Therapy, Product and Application

Table 24. Global Key Players of Targeted Alpha-particle Therapy, Date of Enter into This Industry

Table 25. Mergers & Acquisitions, Expansion Plans

Table 26. Global Targeted Alpha-particle Therapy Market Size by Type (2019-2024) & (US$ Million)

Table 27. Global Targeted Alpha-particle Therapy Revenue Market Share by Type (2019-2024)

Table 28. Global Targeted Alpha-particle Therapy Forecasted Market Size by Type (2025-2030) & (US$ Million)

Table 29. Global Targeted Alpha-particle Therapy Revenue Market Share by Type (2025-2030)

Table 30. Global Targeted Alpha-particle Therapy Market Size by Application (2019-2024) & (US$ Million)

Table 31. Global Targeted Alpha-particle Therapy Revenue Market Share by Application (2019-2024)

Table 32. Global Targeted Alpha-particle Therapy Forecasted Market Size by Application (2025-2030) & (US$ Million)

Table 33. Global Targeted Alpha-particle Therapy Revenue Market Share by Application (2025-2030)

Table 34. North America Targeted Alpha-particle Therapy Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 35. North America Targeted Alpha-particle Therapy Market Size by Country (2019-2024) & (US$ Million)

Table 36. North America Targeted Alpha-particle Therapy Market Size by Country (2025-2030) & (US$ Million)

Table 37. Europe Targeted Alpha-particle Therapy Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 38. Europe Targeted Alpha-particle Therapy Market Size by Country (2019-2024) & (US$ Million)

Table 39. Europe Targeted Alpha-particle Therapy Market Size by Country (2025-2030) & (US$ Million)

Table 40. Asia-Pacific Targeted Alpha-particle Therapy Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 41. Asia-Pacific Targeted Alpha-particle Therapy Market Size by Region (2019-2024) & (US$ Million)

Table 42. Asia-Pacific Targeted Alpha-particle Therapy Market Size by Region (2025-2030) & (US$ Million)

Table 43. Latin America Targeted Alpha-particle Therapy Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 44. Latin America Targeted Alpha-particle Therapy Market Size by Country (2019-2024) & (US$ Million)

Table 45. Latin America Targeted Alpha-particle Therapy Market Size by Country (2025-2030) & (US$ Million)

Table 46. Middle East & Africa Targeted Alpha-particle Therapy Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 47. Middle East & Africa Targeted Alpha-particle Therapy Market Size by Country (2019-2024) & (US$ Million)

Table 48. Middle East & Africa Targeted Alpha-particle Therapy Market Size by Country (2025-2030) & (US$ Million)

Table 49. Bayer Company Details

Table 50. Bayer Business Overview

Table 51. Bayer Targeted Alpha-particle Therapy Product

Table 52. Bayer Revenue in Targeted Alpha-particle Therapy Business (2019-2024) & (US$ Million)

Table 53. Bayer Recent Development

Table 54. Orano Med Company Details

Table 55. Orano Med Business Overview

Table 56. Orano Med Targeted Alpha-particle Therapy Product

Table 57. Orano Med Revenue in Targeted Alpha-particle Therapy Business (2019-2024) & (US$ Million)

Table 58. Orano Med Recent Development

Table 59. Oncoinvent AS Company Details

Table 60. Oncoinvent AS Business Overview

Table 61. Oncoinvent AS Targeted Alpha-particle Therapy Product

Table 62. Oncoinvent AS Revenue in Targeted Alpha-particle Therapy Business (2019-2024) & (US$ Million)

Table 63. Oncoinvent AS Recent Development

Table 64. Perspective Therapeutics Company Details

Table 65. Perspective Therapeutics Business Overview

Table 66. Perspective Therapeutics Targeted Alpha-particle Therapy Product

Table 67. Perspective Therapeutics Revenue in Targeted Alpha-particle Therapy Business (2019-2024) & (US$ Million)

Table 68. Perspective Therapeutics Recent Development

Table 69. Ablaze Pharma Company Details

Table 70. Ablaze Pharma Business Overview

Table 71. Ablaze Pharma Targeted Alpha-particle Therapy Product

Table 72. Ablaze Pharma Revenue in Targeted Alpha-particle Therapy Business (2019-2024) & (US$ Million)

Table 73. Ablaze Pharma Recent Development

Table 74. ARTBIO Company Details

Table 75. ARTBIO Business Overview

Table 76. ARTBIO Targeted Alpha-particle Therapy Product

Table 77. ARTBIO Revenue in Targeted Alpha-particle Therapy Business (2019-2024) & (US$ Million)

Table 78. ARTBIO Recent Development

Table 79. Fusion Pharmaceuticals(AstraZeneca) Company Details

Table 80. Fusion Pharmaceuticals(AstraZeneca) Business Overview

Table 81. Fusion Pharmaceuticals(AstraZeneca) Targeted Alpha-particle Therapy Product

Table 82. Fusion Pharmaceuticals(AstraZeneca) Revenue in Targeted Alpha-particle Therapy Business (2019-2024) & (US$ Million)

Table 83. Fusion Pharmaceuticals(AstraZeneca) Recent Development

Table 84. AlphaGen Therapeutics Company Details

Table 85. AlphaGen Therapeutics Business Overview

Table 86. AlphaGen Therapeutics Targeted Alpha-particle Therapy Product

Table 87. AlphaGen Therapeutics Revenue in Targeted Alpha-particle Therapy Business (2019-2024) & (US$ Million)

Table 88. AlphaGen Therapeutics Recent Development

Table 89. Research Programs/Design for This Report

Table 90. Key Data Information from Secondary Sources

Table 91. Key Data Information from Primary Sources

Table 92. Authors List of This Report

List of Figures

Figure 1. Targeted Alpha-particle Therapy Picture

Figure 2. Global Targeted Alpha-particle Therapy Market Size Comparison by Type (2024-2030) & (US$ Million)

Figure 3. Global Targeted Alpha-particle Therapy Market Share by Type: 2023 VS 2030

Figure 4. Actinium-225 Features

Figure 5. Astatine-211 Features

Figure 6. Lead-212 Features

Figure 7. Bismuth-213 Features

Figure 8. Others Features

Figure 9. Global Targeted Alpha-particle Therapy Market Size by Application (2024-2030) & (US$ Million)

Figure 10. Global Targeted Alpha-particle Therapy Market Share by Application: 2023 VS 2030

Figure 11. Immunotherapy Case Studies

Figure 12. Peritoneal Carcinomas Case Studies

Figure 13. Bone Metastases Case Studies

Figure 14. Leukaemia Case Studies

Figure 15. Melanomas Case Studies

Figure 16. Solid Tumours Case Studies

Figure 17. Targeted Alpha-particle Therapy Report Years Considered

Figure 18. Global Targeted Alpha-particle Therapy Market Size (US$ Million), Year-over-Year: 2019-2030

Figure 19. Global Targeted Alpha-particle Therapy Market Size, (US$ Million), 2019 VS 2023 VS 2030

Figure 20. Global Targeted Alpha-particle Therapy Market Share by Region: 2023 VS 2030

Figure 21. Global Targeted Alpha-particle Therapy Market Share by Players in 2023

Figure 22. Global Top Targeted Alpha-particle Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Targeted Alpha-particle Therapy as of 2023)

Figure 23. The Top 10 and 5 Players Market Share by Targeted Alpha-particle Therapy Revenue in 2023

Figure 24. North America Targeted Alpha-particle Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 25. North America Targeted Alpha-particle Therapy Market Share by Country (2019-2030)

Figure 26. United States Targeted Alpha-particle Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 27. Canada Targeted Alpha-particle Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 28. Europe Targeted Alpha-particle Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 29. Europe Targeted Alpha-particle Therapy Market Share by Country (2019-2030)

Figure 30. Germany Targeted Alpha-particle Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 31. France Targeted Alpha-particle Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 32. U.K. Targeted Alpha-particle Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 33. Italy Targeted Alpha-particle Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 34. Russia Targeted Alpha-particle Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 35. Nordic Countries Targeted Alpha-particle Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 36. Asia-Pacific Targeted Alpha-particle Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 37. Asia-Pacific Targeted Alpha-particle Therapy Market Share by Region (2019-2030)

Figure 38. China Targeted Alpha-particle Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 39. Japan Targeted Alpha-particle Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 40. South Korea Targeted Alpha-particle Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 41. Southeast Asia Targeted Alpha-particle Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 42. India Targeted Alpha-particle Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 43. Australia Targeted Alpha-particle Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 44. Latin America Targeted Alpha-particle Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 45. Latin America Targeted Alpha-particle Therapy Market Share by Country (2019-2030)

Figure 46. Mexico Targeted Alpha-particle Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 47. Brazil Targeted Alpha-particle Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 48. Middle East & Africa Targeted Alpha-particle Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 49. Middle East & Africa Targeted Alpha-particle Therapy Market Share by Country (2019-2030)

Figure 50. Turkey Targeted Alpha-particle Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 51. Saudi Arabia Targeted Alpha-particle Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 52. UAE Targeted Alpha-particle Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 53. Bayer Revenue Growth Rate in Targeted Alpha-particle Therapy Business (2019-2024)

Figure 54. Orano Med Revenue Growth Rate in Targeted Alpha-particle Therapy Business (2019-2024)

Figure 55. Oncoinvent AS Revenue Growth Rate in Targeted Alpha-particle Therapy Business (2019-2024)

Figure 56. Perspective Therapeutics Revenue Growth Rate in Targeted Alpha-particle Therapy Business (2019-2024)

Figure 57. Ablaze Pharma Revenue Growth Rate in Targeted Alpha-particle Therapy Business (2019-2024)

Figure 58. ARTBIO Revenue Growth Rate in Targeted Alpha-particle Therapy Business (2019-2024)

Figure 59. Fusion Pharmaceuticals(AstraZeneca) Revenue Growth Rate in Targeted Alpha-particle Therapy Business (2019-2024)

Figure 60. AlphaGen Therapeutics Revenue Growth Rate in Targeted Alpha-particle Therapy Business (2019-2024)

Figure 61. Bottom-up and Top-down Approaches for This Report

Figure 62. Data Triangulation

Figure 63. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global Targeted Radiotherapy Drug Market Research Report 2024

Global Targeted Radionuclide Therapy Market Research Report 2024

Global Radioimmunotherapy Market Research Report 2025

Global Targeted Radiopharmaceuticals Market Research Report 2024

Global Systemic Radiotherapy Market Research Report 2024

Global Alpha Emitters Market Research Report 2024

Global Therapeutic Radioligands Market Research Report 2024

Global Radioactive Therapeutic Drugs Market Research Report 2024

Global Oncology Targeted Therapy Market Research Report 2025

Global Cancer Targeted Drug Market Research Report 2025

Global Targeted Small Molecule Therapy Market Research Report 2025

Global Radiopharmaceutical Therapy Market Research Report 2025

Global Targeted Small Molecule Drug Market Research Report 2025

Radiopharmaceutical Theranostics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Cancer Targeted Small Molecule Therapy Market Research Report 2025

Global Antibody radionuclide Conjugates Market Research Report 2024

Global Targeted SSTR Radionuclide Drug Conjugates Market Research Report 2024

Global Heavy Ion Therapy Technology Market Research Report 2025

Global Cancer Particle Therapy Market Research Report 2024

RELATED REPORTS

Global Hormonal Therapy for Cancer Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-5L19798

Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Cancer Insurance Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-28I6901

Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Induced Myeloid Leukemia Cell Differentiation Protein Mcl 1 Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-22R9736

Wed Sep 10 00:00:00 UTC 2025

Add to Cart

Global Drugs for Differentiated Thyroid Cancer Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-29A2598

Tue Sep 09 00:00:00 UTC 2025

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions